This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks That Could Rebound in 2011

Charming Shoppes also suffers from poor merchandising and found itself stuck with too much inventory, which the company is addressing. Furthermore, Charming Shoppes is going to have to focus on its private label credit card program which is experiencing declining revenues and returns. This company is now on the hands of a new chief operating officer, and the board is conducting a search for a new chief executive officer.

All of these problems, especially the merchandising issues, will take some time to fix. I am not saying that all three of these stocks will rebound in 2010, but, as a group, I am expecting a rebound. If you were to play this theme, I would do so as a package of all three names, a field bet of sorts.

Talbots is a major holding of Trafelet Capital Management, as of the most recent reporting period, and Robert Rodriguez of FPA Capital has a position in Charming Shoppes.


One stock that I didn't include as one of my health care stocks to consider was Medtronic (MDT), which manufactures and distributes medical devices and equipment. In 2010, the company faced some issues of concern for shareholders.

Medtronic, which has been fighting the FDA over approval of a new medical device, the CoreValve System, received some good news recently from the regulatory agency. The FDA granted conditional approval to Medtronic for a revised design trial study.

Chairman and CEO William Hawkins is expected to retire in April, and the board has initiated a search for his replacement. No reason was given for his decision.

In addition, the company completed the takeover of blood pressure treatment company Ardian earlier this month. The acquisition is expected to be dilutive by 2 cents in its fiscal fourth quarter ending April 2011 and by 5 cents to 6 cents in fiscal 2012.

All of these issues weighed on the stock in 2010, which ended the year down nearly 16%. But as 2011 unfolds, I see the potential for a stock rebound. Medtronic's products will be in ever-increasing demand as baby boomers -- and our population in general -- age. For its fiscal year ended April 2011, earnings are expected to grow by 5%. In the following year, earnings should grow by about 7%. The stock pays a dividend of 2.5%. The balance sheet isn't great, but it's good, with long-term debt of about $10.55 billion only partially offset by cash and short-term investments of about $3.54 billion and long-term investments of about $5.45 billion.

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs